Clinical trial
A Phase 2 Randomized, Double-blind, Placebo-controlled, Proof of Concept Study to Evaluate the Safety and Efficacy of Antroquinonol in Hospitalized Patients With Mild to Moderate Pneumonia Due to COVID-19
NCT04523181 is registered in ClinicalTrials.gov with Golden Biotechnology Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Randomized, Double-blind, Placebo-controlled, Proof of Concept Study to Evaluate the Safety and Efficacy of Antroquinonol in Hospitalized Patients With Mild to Moderate Pneumonia Due to COVID-19
- Lead sponsor
- Golden Biotechnology Corporation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 15, 2020
- Completion date
- December 23, 2021
- Enrollment
- 124 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.